MEG Energy Corp. (MEG.TO)
| Previous Close | 4.6400 |
| Open | 4.5000 |
| Bid | 4.4000 x N/A |
| Ask | 4.4100 x N/A |
| Day's Range | 4.3600 - 4.5900 |
| 52 Week Range | 1.1300 - 7.6100 |
| Volume | 2,536,005 |
| Avg. Volume | 3,201,517 |
| Market Cap | 1.404B |
| Beta (5Y Monthly) | 3.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1620 |
| Earnings Date | Mar. 02, 2021 - Mar. 08, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.27 |
- Baystreet
Stocks Jump on Jobs Figures, Energy Strength
Canada's main stock index rose on Friday to hover near 10-month highs, boosted by a jump in oil prices, ...
- The Motley Fool
Market Crash: If You’re in These 2 Stocks, You’d Better Take Profits Now
Warning! The stocks in these two industries could see their recent gains evaporate with the blink of an eye.The post Market Crash: If You're in These 2 Stocks, You'd Better Take Profits Now appeared first on The Motley Fool Canada.
- CNW Group
Advisory - Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid
OTTAWA, ON, Oct. 30, 2020 /CNW/ -Summary Product: Prescription and over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) Issue: Health Canada is investigating the use of NSAIDs at 20 weeks or later in pregnancy and the rare, but serious, risk of kidney problems in an unborn baby that can lead to low levels of amniotic fluid and possible complications, in response to a Drug Safety Communication  recently released by the U.
